ABCL: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-137,467	-80,348
Depreciation of property and equipment	13,257	8,951
Amortization and impairment of intangible assets	2,791	1,851
Amortization of operating lease right-of-use assets	4,853	2,863
Stock-based compensation	42,888	28,993
Fair value (gain)/loss on contingent consideration	-613	-
Other	-988	667
Research fees and grants receivable	15,957	12,524
Income taxes payable (receivable)	-19,792	-7,588
Accounts payable and accrued liabilities	-2,286	-7,356
Deferred revenue	2,316	9,361
Deferred grant income	2,834	1,681
Fair value gain on contingent consideration	-	-737
Other assets	-14,078	-13,450
Net cash used in operating activities	-96,552	-43,958
Purchases of property and equipment	32,929	24,001
Purchase of marketable securities	324,704	291,542
Proceeds from marketable securities	386,536	303,437
Receipt of grant funding	7,366	6,448
Long-term investments and other assets	16,771	13,783
Investment in equity accounted investees	6,886	4,435
Net cash provided by investing activities	12,612	-23,876
Payment of liability for in-licensing agreement and other	9,240	-
Proceeds from other liabilities and exercise of stock options	19,207	11,653
Payment of contingent consideration and other	-	9,058
Net cash provided by financing activities	9,967	2,595
Effect of exchange rate changes on cash and cash equivalents	807	1,351
Decrease in cash and cash equivalents	-73,166	-63,888
Cash and cash equivalents at beginning of period	183,615	-
Cash and cash equivalents at end of period	110,449	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

ABCL: the cashflow